PATHOLOGIC STAGE-SPECIFIC MARKERS FOR DIAGNOSING PROGNOSIS AND DETERMINING TREATMENT STRATEGY FOR RENAL CANCER PATIENTS

摘要

The present invention relates to markers for diagnosing a prognosis or a difference in effects of renal cancer treatment depending on the pathologic stage of renal cancer patients. A survival rate, recurrence rate or metastasis rate of renal cancer of a particular pathologic stage respectively is related to the mutation of genes, of the present invention, in renal cancer patients, and thus the mutated genes of the present invention can be used as markers in predicting, on the basis of pathologic stage, the difference in effects of renal cancer treatment or the prognosis of renal cancer patients.;COPYRIGHT KIPO 2019